VANGUARD GROUP INC - CONTEXT THERAPEUTICS INC ownership

CONTEXT THERAPEUTICS INC's ticker is and the CUSIP is 21077P108. A total of 20 filers reported holding CONTEXT THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of CONTEXT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$896,171
-2.5%
593,491
+3.3%
0.00%
Q2 2023$919,520
+185.2%
574,700
+0.2%
0.00%
Q1 2023$322,365
-22.8%
573,400
-10.5%
0.00%
Q4 2022$417,650
-41.3%
640,863
+0.0%
0.00%
Q3 2022$711,000
-46.7%
640,699
+1.9%
0.00%
Q2 2022$1,333,000
+159.8%
628,979
+166.2%
0.00%
Q1 2022$513,000
-10.2%
236,279
+10.1%
0.00%
Q4 2021$571,000214,6790.00%
Other shareholders
CONTEXT THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 1,165,100$2,528,0000.38%
Worth Venture Partners, LLC 317,729$689,0000.32%
Affinity Asset Advisors, LLC 777,610$1,687,0000.27%
Knoll Capital Management, LLC 139,520$303,0000.19%
swisspartners Ltd. 42,235$92,0000.07%
Veritable, L.P. 110,249$239,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 49,912$108,0000.00%
MORGAN STANLEY 10,000$22,0000.00%
BlackRock Inc. 16,961$37,0000.00%
Citadel Advisors 18,516$40,0000.00%
View complete list of CONTEXT THERAPEUTICS INC shareholders